MSD Animal Health Greece

What MSD Animal Health Greece does

MSD Animal Health Greece operates as the Greek subsidiary of MSD (Merck & Co., Inc.), legally registered as INTERVET HELLAS Single Member S.A. and headquartered in Alimos, Greece. The company was established in its current form following the November 2009 global merger of Merck Sharp & Dohme and Schering-Plough, which integrated Intervet Hellas M.A.E. into one of the world's largest pharmaceutical companies. It serves the veterinary pharmaceutical market in Greece and Cyprus with a product portfolio spanning vaccines, pharmaceuticals, and health management solutions for over ten animal species, including livestock (cattle, pigs, sheep, goats, poultry, horses), companion animals (dogs, cats), and aquaculture (fish). Key product categories include cloned vaccines, subunit vaccines, multivalent clostridial vaccines, NSAIDs, antimicrobials, antiparasitics, immunostimulant solutions, and specialized devices such as intradermal vaccination syringes.

The company distributes its products through an extensive commercial network via Intervet Hellas M.A.E. in Greece and Cycon Chemicals LTD in Cyprus, targeting veterinarians, livestock farmers, animal producers, pet owners, fish farmers, and state veterinary services. Its go-to-market is sales-led, built on direct sales relationships and authorized distribution channels. The company emphasizes the One Health approach, addressing antimicrobial resistance, food safety, zoonotic diseases, and sustainable animal production.

MSD Animal Health Greece is a privately-held subsidiary with approximately 20 employees and no publicly disclosed revenue figures. It benefits from the global MSD Animal Health division's R&D capabilities, including pioneering products such as the first cloned Newcastle disease vaccine, first subunit vaccine against Aujeszky's disease, and first PRRS vaccine. The company maintains a digital presence through its corporate website, Facebook, LinkedIn, and YouTube channels. As a wholly-owned subsidiary of MSD (Merck & Co., Inc.), its strategic direction is aligned with the global animal health division's priorities.

Name

MSD Animal Health Greece

Legal name

INTERVET HELLAS Single Member S.A.

Website

https://msd-animal-health.gr

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

MSD Animal Health Greece (Intervet Hellas S.A.) is the Greek subsidiary of MSD (Merck & Co., Inc.), distributing veterinary medicines, vaccines, and health management solutions for livestock, companion animals, and aquaculture across Greece and Cyprus.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Veterinary Services (54194), Veterinary Services (541940)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Veterinary Vaccines (HLAIAEAH)

akta.pro secondary industries

Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM), Vaccination, Parasite Control & Immunization Programs (AFACADAG)

Keywords

• Veterinary pharmaceuticals
• Animal vaccines
• Livestock health solutions
• Companion animal medicines
• Aquaculture vaccines

Headquarters

HQ city

Alimos

HQ country

Greece

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Veterinary Pharmaceuticals and Vaccines: MSD Animal Health Greece generates revenue through the sale of veterinary medicines, vaccines, and health management solutions for various animal species including livestock (cattle, pigs, sheep, goats, poultry, horses) and companion animals (dogs, cats), as well as aquaculture (fish).

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

MSD Animal Health Greece operates as the Greek subsidiary of MSD (Merck & Co., Inc.), developing, manufacturing, and distributing veterinary medicines, vaccines, and health management solutions for livestock (cattle, pigs, sheep, goats, poultry, horses), companion animals (dogs, cats), and aquaculture (fish). The company sells a broad portfolio of pharmaceuticals including NSAIDs, antimicrobials, antiparasitics, cloned vaccines, subunit vaccines, multivalent clostridial vaccines, immunostimulant solutions, and specialized devices such as intradermal vaccination syringes, delivered through an extensive distribution network across Greece and Cyprus.

Product overview

MSD Animal Health Greece (Intervet Hellas M.A.E.) operates as the Greek subsidiary of MSD (Merck & Co., Inc.) and offers a comprehensive portfolio of veterinary medicines, vaccines, and animal health solutions. The product offering spans multiple animal species: fish (aquaculture vaccines), poultry, swine, bovine, small ruminants (sheep/goats), horses, rabbits, dogs, and cats. Key product categories include vaccines (cloned, subunit, and multivalent vaccines for various diseases), pharmaceuticals (NSAIDs, antimicrobials, antiparasitics), immunostimulant solutions, and specialized devices such as intradermal vaccination syringes. The company also provides health management solutions and services aimed at improving productivity of livestock animals. Products are distributed through an extensive commercial distribution network across Greece and Cyprus.

Differentiator

Problem solved

Functional benefit

Products and services

• Poultry Vaccines Vaccines for poultry health including the first cloned vaccine against Newcastle disease, avian influenza vaccines, and vaccines for various poultry diseases.
• Swine Vaccines and Pharmaceuticals Vaccines and pharmaceuticals for swine including the first subunit vaccine against Aujeszky's disease, first PRRS vaccine, first vaccine against atrophic rhinitis with high-purity toxins, and clostridial vaccines.
• Bovine Vaccines and Pharmaceuticals Veterinary vaccines and pharmaceuticals for cattle including multivalent vaccines against clostridia for cattle.
• Small Ruminant Vaccines Multivalent clostridial vaccines for goats and sheep.
• Companion Animal Products (Dogs and Cats) Veterinary medicines and vaccines for dogs and cats, delivered through an extensive commercial distribution network.
• Equine Products Veterinary pharmaceutical products for horses.
• Aquaculture Vaccines Vaccines against vibriosis and pasteurellosis for use in fish farms (aquaculture).
• Rabbit Health Products Veterinary products for rabbits.
• Sheep Products Veterinary pharmaceutical products for sheep.
• Intramammary and Injectable Pharmaceuticals for Livestock Including pioneering NSAIDs for injectable administration, antimicrobial preparations, and innovative antiparasitics for productive animals.
• Intradermal Vaccine Administration Syringe Specialized syringe for intradermal administration of vaccines in pigs.
• Immunostimulant Solutions A large series of immunostimulant solutions designed to enhance immune response when used in conjunction with vaccine administration.

Quantifiable outcome

• Better animal health leads to higher productivity, lower CO2 emissions, and reduced food insecurity

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Cycon Chemicals LTDminorChannel Partner/ Reseller/ DistributorCycon Chemicals LTD, based in Nicosia, Cyprus, serves as the distribution partner for MSD Animal Health products in Cyprus. Nearly all products that circulate in Greece are also distributed in Cyprus through this partner.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Zoetis: The world's largest standalone animal health company, offering a directly overlapping portfolio of veterinary vaccines, parasiticides, and pharmaceuticals for livestock and companion animals. Comparable to MSD Animal Health Greece in product breadth and species coverage, though operating at global rather than country scale.
• Elanco Animal Health: Global animal health company offering vaccines, parasiticides, and therapeutics for livestock and pets. Overlaps with MSD Animal Health Greece across companion animal parasiticides and livestock pharmaceuticals across European markets.
• Boehringer Ingelheim Animal Health: Top-three global animal health player with a strong vaccine portfolio across poultry, swine, and companion animals. Directly competes with MSD's livestock and companion animal vaccines in EMEA, including Greece and Cyprus.

Direct peers

• Phibro Animal Health: Animal health and nutrition company with a portfolio of vaccines, antimicrobials, and nutritional specialties for livestock and poultry. Comparable in vaccine and pharmaceutical coverage, particularly in the poultry and swine segments served by MSD AH Greece.
• HIPRA: Spanish animal health company specializing in veterinary vaccines, particularly for swine, poultry, and ruminants. A direct competitor in Mediterranean livestock vaccines and the closest regional peer to MSD Animal Health Greece by geography.
• Vetoquinol: Mid-sized European animal health company focused on veterinary pharmaceuticals and vaccines for livestock and companion animals. Comparable in scale and product mix to MSD Animal Health Greece, with overlapping presence in European livestock markets.
• Virbac: France-headquartered animal health company with a portfolio in veterinary vaccines, parasiticides, and pharmaceuticals for livestock and companion animals. Highly comparable mid-sized direct peer with similar species and therapeutic coverage to MSD Animal Health Greece.
• Ceva Santé Animale: Independent global animal health company with strong positions in poultry and swine vaccines and a growing companion animal portfolio. Directly comparable to MSD AH Greece in livestock vaccine focus and Mediterranean European footprint.

Emerging players

• Dechra Pharmaceuticals: UK-listed animal health company focused on veterinary pharmaceuticals and specialty products, particularly in companion animals and equine. Overlaps with the companion animal and equine portions of MSD Animal Health Greece's portfolio.
• IDT Biologika: German-based veterinary vaccine manufacturer and CDMO with strong livestock vaccine capabilities. Comparable to MSD Animal Health Greece in livestock vaccine focus and European distribution, though smaller in scale and geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCFOuNexrgqxWtElTAgunguQ
• Facebookfacebook.com/MSD.Animal.Health.Greece
• LinkedInlinkedin.com/company/msd-animal-health-greece

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MSD Animal Health Greece